4//SEC Filing
Davis Matthew W. 4
Accession 0001214659-25-016275
CIK 0001398733other
Filed
Nov 11, 7:00 PM ET
Accepted
Nov 12, 9:35 AM ET
Size
7.3 KB
Accession
0001214659-25-016275
Insider Transaction Report
Form 4
Davis Matthew W.
Chief Development Officer
Transactions
- Award
Common Stock
2025-11-10+50,000→ 50,000 total - Award
Non-Qualified Stock Option (right to buy)
2025-11-10+50,000→ 50,000 totalExercise: $5.58Exp: 2035-11-10→ Common Stock (50,000 underlying)
Footnotes (2)
- [F1]The Common Stock is represented by restricted stock which will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment.
- [F2]The option will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment.
Documents
Issuer
Aquestive Therapeutics, Inc.
CIK 0001398733
Entity typeother
Related Parties
1- filerCIK 0002094283
Filing Metadata
- Form type
- 4
- Filed
- Nov 11, 7:00 PM ET
- Accepted
- Nov 12, 9:35 AM ET
- Size
- 7.3 KB